SCHEMBL6157969

SCHEMBL6157969

C=CCOc1c(Cl)cc(C(=O)NC2CCC(=O)N(C)N(C(C)C(=O)OCC)C2=O)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TP53 P04637 1/20 0.33
MDM2 Q00987 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP2D6 P10635 1/20 0.33
HPGD P15428 1/20 0.33
XIAP P98170 1/20 0.32
SCN9A Q15858 1/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
PPOX P50336 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6158994 0.91 SMN1; SMN2 (0.36) HSD17B10SMN1; SMN2LMNATSHRMEN1
SCHEMBL6158985 0.69 CASP1 (0.46)
SCHEMBL6158424 0.67 TP53 (0.37) TSHRMEN1KMT2ATP53MDM2
SCHEMBL6159297 0.66 MME (0.40) RIPK1
SCHEMBL6159420 0.64 XIAP (0.38) XIAP
SCHEMBL10024170 0.64 TAS1R3 (0.46) HSD17B10SMN1; SMN2LMNATSHRMEN1
SCHEMBL10024169 0.64 TAS1R3 (0.46) HSD17B10SMN1; SMN2LMNATSHRMEN1
SCHEMBL6159133 0.62 L3MBTL1 (0.46) HSD17B10TSHRMEN1KMT2ATP53
SCHEMBL10024166 0.62 NPC1 (0.42) HSD17B10SMN1; SMN2LMNATSHRMEN1
SCHEMBL3469589 0.61 ACE (0.46) SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1062210-B1 1,2-DIAZEPANE DERIVATIVES AS INTERLEUKIN-1BETA CONVERTING ENZYME INHIBITORS VERTEX PHARMA (US) 2005-06-01 EP disclosed
US-6426413-B1 SUCH AS (N-BENZYLOXYCARBONYL-HYDRAZINO)-ACETIC ACID TERT-BUTYL ESTER; FOR PREVENTING AND TREATING INTERLEUKIN-MEDIATED DISEASES, APOPTOSIS, AUTOIMMUNE DISEASES, BONE DISORDERS, PROLIFERATIVE DISORDERS, INFECTIONS, AND DEGENERATIVE DISEASES VERTEX PHARMACEUTICALS INCORPORATED 2002-07-30 US disclosed